PSI Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
PSI Advisors's BMY Position: Q2 2025 in Review
PSI Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 4,854 shares — an estimated $296K sold.
PSI Advisors first reported a position in BMY in Q4 2019 and held it in 22 quarters. The position peaked at $1.09M in Q2 2021. 2,298 funds tracked by Wall St. Rank hold BMY as of Q2 2025.
- PSI Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
- PSI Advisors sold 4,854 Bristol-Myers Squibb shares in Q2 2025, an estimated $296K.
- PSI Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 22 quarters.
- PSI Advisors's Bristol-Myers Squibb position peaked at $1.09M in Q2 2021.
- 2,298 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.
Based on PSI Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.